| Record ID | marc_records_scriblio_net/part12.dat:197242328:1047 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part12.dat:197242328:1047?format=raw |
LEADER: 01047cam 2200313 a 4500
001 81018923 //r91
003 DLC
005 19911113084948.1
008 811117s1982 enka b 00110 eng
010 $a 81018923 //r91
020 $a0192612395 :$c$59.00
040 $aDLC$cDLC$dDLC$dOCoLC
050 00 $aRM666.H87$bM57 1982
060 $aQU 83 M678p
082 00 $a615/.718$219
100 10 $aMishler, John Milton,$d1946-
245 10 $aPharmacology of hydroxyethyl starch :$buse in therapy and blood banking /$cJohn Milton Mishler IV.
260 0 $aOxford ;$aNew York :$bOxford University Press,$c1982.
300 $axii, 207 p. :$bill. ;$c24 cm.
440 0 $aOxford medical publications
504 $aBibliography: p. 171-202.
500 $aIncludes index.
650 0 $aHydroxyethyl starch$xPhysiological effect.
650 0 $aHydroxyethyl starch$xTherapeutic use.
650 0 $aBlood plasma substitutes.
650 2 $aStarch$xPharmacodynamics.
650 2 $aStarch$xTherapeutic use.
650 2 $aPlasma volume.
650 2 $aBlood banks.